Microbot Medical Inc. (FRA:CY9D)
Germany flag Germany · Delayed Price · Currency is EUR
2.300
+0.329 (16.69%)
At close: Nov 28, 2025

Microbot Medical Company Description

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology.

The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations.

It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter.

The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures.

Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Microbot Medical Inc.
CountryUnited States
Founded2010
IndustryElectromedical and Electrotherapeutic Apparatus
Employees20
CEOHarel Gadot

Contact Details

Address:
175 Derby Street
Hingham, Delaware 02043
United States
Phone781 875 3605
Websitemicrobotmedical.com

Stock Details

Ticker SymbolCY9D
ExchangeFrankfurt Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code3845

Key Executives

NamePosition
Harel GadotChief Executive Officer
Rachel VakninChief Financial Officer
Michal AhuviaChief Operating Officer